Van Eck Associates Corp Boston Scientific Corp Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 57,894 shares of BSX stock, worth $5.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

57,894

Previous 49,012 18.12%

Holding current value

$5.9 Million

Previous $3.77 Million 34.15%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$72.96 - $84.0 $648,030 - $746,088	8,882 Added 18.12%	57,894 $5.06 Million
Q2 2024 Jul 31, 2024	BUY	$67.33 - $77.71 $171,085 - $197,461	2,541 Added 5.47%	49,012 $3.77 Million
Q1 2024 Apr 30, 2024	SELL	$57.6 - $68.62 $341,798 - $407,191	-5,934 Reduced 11.32%	46,471 $3.18 Million
Q4 2023 Feb 05, 2024	BUY	$48.64 - $57.81 $80,693 - $95,906	1,659 Added 3.27%	52,405 $3.03 Million
Q3 2023 Nov 08, 2023	SELL	$50.19 - $54.68 $72,022 - $78,465	-1,435 Reduced 2.75%	50,746 $2.68 Million
Q2 2023 Aug 03, 2023	SELL	$49.72 - $54.64 $12,628 - $13,878	-254 Reduced 0.48%	52,181 $2.82 Million
Q1 2023 May 03, 2023	SELL	$45.09 - $50.03 $124,087 - $137,682	-2,752 Reduced 4.99%	52,435 $2.62 Million
Q4 2022 Feb 08, 2023	BUY	$39.56 - $47.22 $66,935 - $79,896	1,692 Added 3.16%	55,187 $2.55 Million
Q3 2022 Oct 27, 2022	BUY	$36.71 - $109.66 $180,246 - $538,430	4,910 Added 10.11%	53,495 $2.07 Million
Q2 2022 Aug 03, 2022	BUY	$35.24 - $47.1 $69,281 - $92,598	1,966 Added 4.22%	48,585 $1.81 Million
Q1 2022 May 10, 2022	SELL	$40.9 - $45.1 $132,802 - $146,439	-3,247 Reduced 6.51%	46,619 $2.07 Million
Q4 2021 Jan 26, 2022	BUY	$38.07 - $44.87 $1.25 Million - $1.47 Million	32,844 Added 192.95%	49,866 $2.12 Million
Q3 2021 Nov 03, 2021	BUY	$41.23 - $45.88 $52,032 - $57,900	1,262 Added 8.01%	17,022 $739,000
Q2 2021 Aug 10, 2021	SELL	$38.58 - $44.24 $925 - $1,061	-24 Reduced 0.15%	15,760 $674,000
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $137,094 - $154,197	3,887 Added 32.67%	15,784 $610,000
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $17,667 - $21,663	-513 Reduced 4.13%	11,897 $455,000
Q2 2020 Aug 10, 2020	SELL	$30.19 - $39.11 $223,043 - $288,944	-7,388 Reduced 37.32%	12,410 $436,000
Q1 2020 May 12, 2020	SELL	$25.83 - $45.71 $448,124 - $793,022	-17,349 Reduced 46.7%	19,798 $646,000
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $57,297 - $68,644	1,513 Added 4.25%	37,147 $1.68 Million
Q3 2019 Nov 08, 2019	BUY	$40.31 - $43.45 $120,285 - $129,654	2,984 Added 9.14%	35,634 $1.45 Million
Q2 2019 Aug 07, 2019	BUY	$34.91 - $42.98 $543,478 - $669,112	15,568 Added 91.14%	32,650 $1.4 Million
Q1 2019 May 13, 2019	BUY	$32.91 - $40.75 $562,168 - $696,091	17,082 New	17,082 $656,000

Others Institutions Holding BSX

# of Institutions

1,568

Shares Held

1.18B

Call Options Held

6.82M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $146B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Boston Scientific Corp Transaction History